Nitric oxide, iNOS, and inflammation in cystic fibrosis

Journal of Pathology

Volumn 190, Issue 2, 2000, Pages 115-116

  Downey, D ^a   Elborn, J S ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

Cystic fibrosis; iNOS; Nitric oxide and neutrophils

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

CELL PROTECTION; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME POLYMORPHISM; HUMAN; HUMAN TISSUE; INFLAMMATION; LUNG INJURY; LUNG SEQUESTRATION; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SHORT SURVEY;

CYSTIC FIBROSIS; HUMANS; INFLAMMATION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II;

EID: 0033980072     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(200002)190:2<115::AID-PATH491>3.0.CO;2-V     Document Type: Short Survey

References (25)

1. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245: 1066-1073.
2. Denning GM, Ostedgaard LS, Welsh MJ. Abnormal localization of cystic fibrosis transmembrane conductance regulator in primary cultures of cystic fibrosis airway-epithelia. J Cell Biol 1992; 118: 551-559.
3. Smith JJ, Travis SM, Greenberg EP, Welsh MJ. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 1996; 85: 229-236.
4. Konstan MW, Berger M. Infection and inflammation of the lung in cystic fibrosis. In Cystic Fibrosis, Davis P (ed), Marcel Dekker: New York, 1993; 291-296.
5. Schmidt HHHW, Walter U. NO at work. Cell 1994; 78: 919-925.
6. Warner RL, Paine RIII, Christensen PJ, et al. Lung sources and cytokine requirements for in vivo expression of inducible nitric oxide synthase. Am J Respir Cell Mol Biol 1995; 12: 649-661.
7. Meng Q-H, Springall DR, Bishop AE, et al. Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis. J Pathol 1998; 184: 323-331.
8. Francoeur C, Denis M. Nitric oxide and interleukin-8 as inflammatory components of cystic fibrosis. Inflammation 1995; 19: 587-598.
9. Lundberg JO, Nordvall SL, Weitzberg E, Kollberg H, Alving K. Exhaled nitric oxide in paediatric asthma and cystic fibrosis. Arch Dis Child 1996; 75: 323-326.
10. Balfour-Lynn IM, Laverty A, Dinwiddle R. Reduced upper airway nitric oxide in cystic fibrosis. Arch Dis Child 1996; 75: 319-322.
11. Dotsch J, Demirakca S, Terbrack HG, Huls G, Rascher W, Kuhl PG. Eur Respir J 1996; 9: 2537-2540.
12. Meng Q-H, Polak JM, Edgar AJ, et al. Neutrophils enhance expression of inducible nitric oxide synthase in human normal but not cystic fibrosis bronchial epithelial cells. J Pathol 2000; 190: 126-132.
13. Grasemann H, Michler E, Wallot M, Ratjen F. Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis. Pediatr Pulmonol 1997; 24: 173-177.
14. Linnane SJ, Keatings VM, Costello CM, et al. Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis. Am J Respir Crit Care Med 1998; 158: 207-212.
15. Grasemann H, Ioannidis I, Tomkiewicz RP, de Groot H, Rubin BK, Ratjen F. Nitric oxide metabolites in cystic fibrosis lung disease. Arch Dis Child 1998; 78: 49-53.
16. Sato Y, Walley KR, Klut ME, et al. Nitric oxide reduces the sequestration of polymorphonuclear leucocytes in lung by changing deformability and CD18 expression. Am J Respir Crit Care Med 1999; 159: 1469-1476.
17. Hickey MJ, Sharkey KA, Sihola EG, et al. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte endothelium interactions in endotoxemia. FASEB J 1997; 11: 955-964.
18. Nathan C. Inducible nitric oxide synthase: what difference does it make? J Clin Invest 1997; 10: 2417-2423.
19. Evans TJ, Buttery LDK, Carpenter A, Springall DR, Polak JM, Cohen J. Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria. Proc Natl Acad Sci USA 1996; 93: 9553-9558.
20. Beckman JS, Beckman TW. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 1990; 87: 1620-1624.
21. Smith AW, Green J, Eden CE, Watson ML. Nitric oxide-induced potentiation of the killing of Burkholderia cepacia by reactive oxygen species: implications for cystic fibrosis. J Med Microbiol 1999; 48: 419-423.
22. Malawista SE, Montgomery RR, van Blaricom G. Evidence for reactive nitrogen intermediates in killing of staphylococci by human neutrophil cytoplasts. J Clin Invest 1992; 90: 631-636.
23. Beckman JS, Koppenol WH. Nitric oxide, superoxide and peroxynitrite: the good, the bad and the ugly. Am J Physiol 1996; 271: C1424-C1437.
24. Barnes PJ. Nitric oxide and airway disease. Ann Med 1995; 27: 389-393.
25. Akaike T, Noguchi Y, Ijiri S, et al. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc Natl Acad Sci U S A 1996; 93: 2448-2453.